Call Us - We're Easy to Talk To (214) 999-9999

FDA Adds Warning Of Celgene Risks For Elderly

The Dow Jones (12/31, Dooren) reported, “The Food and Drug Administration said Wednesday Celgene Corp. (CELG) added an additional warning to its blood-clot busting drug Innohep stating it could increase the risk of death in elderly patients with kidney problems.” This past “July the company said the risk appeared to apply to elderly patients age 90 and older and updated the drug’s label to warn of that risk” and “earlier this month, the FDA said the risk appeared for elderly patients age 70 and older and said it was asking Celgene to further revise the warning.” In a letter that was posted on the FDA’s website from Celgen to doctors and other health professionals says, “we now regard the risks for Innohep as applying to all elderly patients with renal insufficiency and have further revised the label to include this information as a warning.”

The AP (1/1, Johnson) reported, “The FDA said it had received 383 reports of side effects and complications worldwide, including 96 deaths, as of Oct. 15, 2008,” and it “expects to get a final report from the study in January and will complete its review soon after that.”

Courtesy of American Association for Justice news release.

Bob Kraft

I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law and Social Security Disability.

About This Blog

The title of this blog reflects my attitude toward those government agencies and insurance companies that routinely mistreat injured or disabled people. As a Dallas, Texas lawyer, I've spent more than 45 years trying to help those poor folk, and I have been frustrated daily by the actions of the people on the other side of their claims. (Sorry if I offended you...)

If you find this type of information interesting or helpful, please visit my law firm's main website at You will find many more articles and links. Thank you for your time.

Find us on your preferred network